Xinfuda Achieves ISO 13485 Certification, Strengthening Global Medical Device Compliance

Founded in 2001, Xinfuda specializes in pharmaceutical packaging and medical device components, serving clients across Asia, Europe, and the Americas with high-quality, compliant solutions.announced that it has successfully obtained ISO 13485 certification, marking a significant milestone in the company's commitment to quality management and regulatory compliance in the medical device sector.

injecion pen types

ISO 13485 is an internationally recognized standard specifically designed for quality management systems in the medical device industry. It ensures that manufacturers consistently meet both customer and regulatory requirements across the entire product lifecycle, including design, production, and distribution.

Elevating Quality Standards for Injection Pens and Pharmaceutical Packaging

With over two decades of experience in pharmaceutical packaging and drug delivery systems, Xinfuda has continuously invested in advanced manufacturing capabilities and strict quality control systems. The company's product portfolio includes:

Injection pens (disposable and reusable)

Pharmaceutical bottles and closures

COP vials and desiccant packaging

Drug delivery components

Its injection pen platforms already comply with international technical standards such as ISO 11608, ensuring high precision and safety in drug delivery applications.

ISO13485

The addition of ISO 13485 certification further enhances Xinfuda’s ability to serve global pharmaceutical and biotech companies with compliant, high-quality solutions.

Supporting the Future of Drug Delivery Innovation

As demand grows for advanced drug delivery systems such as GLP-1 injection pens, biologics packaging, and combination products, Xinfuda is well-positioned to support global pharmaceutical partners with:

Scalable manufacturing

Custom design and OEM/ODM capabilities

Regulatory-ready device platforms

The ISO 13485 certification reinforces the company’s role as a trusted partner in the evolving healthcare and biopharmaceutical landscape.